Indian Exemestane Exporters: Complete Supplier Ranking with Market Share — 87 Manufacturers (2026) — TransData Nexus

Q: Who is the largest exemestane supplier from India?

INTAS PHARMACEUTICALS LIMITED is the largest exemestane exporter from India with a 31.1% market share and export value of $4.5M.

Q: How many exemestane suppliers are there in India?

There are 87 active exemestane exporters in India, collectively shipping $14.5M worth of exemestane across 1,533 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top exemestane suppliers from India?

The top 5 exemestane suppliers from India — INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, CIPLA LIMITED — together control 78.1% of total exemestane export value from India.

Suresh Sormare

Exemestane

India Pharmaceutical Trade Intelligence

$14.5M87 Suppliers57 CountriesHS 30049049

ExportsIndia → UNITED STATES39.3%India → BRAZIL12.2%

ImportsUNITED STATES → India$163.0K ITALY → India$146.4K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: CARDINAL HEALTH

Exemestane Suppliers from India (2026) — 87 Exporters, $14.5M Market | TransData Nexus | TransData Nexus

Who Exports Exemestane from India — 87 Suppliers Behind a $14.5M Market

India's exemestane export market is supplied by 87 active exporters who collectively shipped $14.5M across 1,533 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 31.1% market share, followed by EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 78.1% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Exemestane Suppliers & Exporters — 87 manufacturers, $14.5M export market, top destinations and formulations — Exemestane supplier data — 87 exporters · $14.5M market · 1,533 shipmentsTransData Nexus · Indian Customs Data

Top Exemestane Exporters from India — Ranked by Export Value

INTAS PHARMACEUTICALS LIMITED is the leading exemestane exporter from India, holding a 31.1% share of the $14.5M market across 1,533 shipments from 87 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, CIPLA LIMITED — collectively control 78.1% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (31.1%), EUGIA PHARMA SPECIALITIES LIMITED (15.4%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (12.3%), MSN LABORATORIES PRIVATE LIMITED (12.0%), CIPLA LIMITED (7.3%).

Top Exemestane Exporters from India

Ranked by export value · 87 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Exemestane Exporters from India — Ranked by Export Value. 87 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Exemestane exporters

Certification and compliance status for top Exemestane suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Intas Pharmaceuticals Limited	Warning Letter issued in	Yes	Yes	Not verified	Received FDA Warning Letter in November 2023 for CGMP violations; holds WHO-GMP
Sun Pharmaceutical Industries Limited	Warning Letter issued in	Yes	Yes	Not verified	Received FDA Warning Letter in June 2024; holds WHO-GMP and EU GMP certification
Cipla Limited	Approved	Yes	Yes	Multiple	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Zydus Lifesciences Limited	Warning Letter issued in	Yes	Yes	Not verified	Received FDA Warning Letter in August 2024; holds WHO-GMP and EU GMP certificati
Eugia Pharma Specialities Limited	Warning Letter issued in	Unknown	Unknown	Not verified	Received FDA Warning Letter in August 2024; WHO-GMP and EU GMP statuses are unkn
MSN Laboratories Private Limited	Approved	Yes	Yes	Multiple	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Cadila Healthcare Limited	Approved	Yes	Yes	Multiple	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.
Intas Pharmaceuticals Ltd	Warning Letter issued in	Yes	Yes	Not verified	Received FDA Warning Letter in November 2023 for CGMP violations; holds WHO-GMP
Jodas Expoim Private Limited	Approved	Yes	Yes	Multiple	FDA-approved with multiple ANDAs; holds WHO-GMP and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 9 leading Exemestane exporters from India. 4 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 5 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Exemestane sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts a robust ecosystem of pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and bulk drug manufacturing. Notable firms such as Dr. Reddy's Laboratories and Aurobindo Pharma have established extensive operations in the region, leveraging Hyderabad's strategic advantages in infrastructure and skilled workforce. The presence of Hyderabad Pharma City, recognized as a National Investment Manufacturing Zone, further underscores the city's pivotal role in India's pharmaceutical landscape.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat has emerged as a significant hub for pharmaceutical formulations. This region is home to leading companies like Alembic Pharmaceuticals, headquartered in Vadodara, which specializes in the production of formulations across various therapeutic areas. The state's pharmaceutical sector is characterized by a strong focus on innovation and quality, supported by a well-established industrial infrastructure and a skilled workforce. The presence of multiple pharmaceutical clusters dedicated to formulations and biogenerics highlights the region's strategic importance in the pharmaceutical industry. (mediaindia.eu)

Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Exemestane exporters from India

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

In March 2025, Sun Pharma announced the acquisition of Checkpoint Therapeutics, a Waltham, Massachusetts-based company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's oncology portfolio, potentially influencing its strategic focus and resource allocation, which may indirectly affect its Exemestane export activities.

Impact: This acquisition is expected to enhance Sun Pharma's oncology portfolio, potentially influencing its strategic focus and resource allocation, which may indirectly affect its Exemestane export activities.

TransData Nexus Industry Research · Regulatory filings and press releases · Mar 2026

Common Questions — Exemestane Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which exemestane supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 260 recorded shipments worth $4.5M. EUGIA PHARMA SPECIALITIES LIMITED (27 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (18 shipments) are also established high-volume exporters.

Q How many exemestane manufacturers are there in India?

India has 87 active exemestane exporters with a combined export market of $14.5M across 1,533 shipments to 57 countries. The top 5 suppliers hold 78.1% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for exemestane from India?

Average FOB unit price: $47.52 per unit, ranging from $0.01 to $6892.13. Average shipment value: $9.4K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Exemestane

Exemestane

Who Exports Exemestane from India — 87 Suppliers Behind a $14.5M Market

Top Exemestane Exporters from India — Ranked by Export Value

Top Exemestane Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Common Questions — Exemestane Suppliers from India

Q Which exemestane supplier from India is the most reliable for bulk orders?

Q How many exemestane manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for exemestane from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Analysis Methodology